Citations (1)
Keep up to date with the latest research on this topic with citation updates for this article.
OncoImmunology
Volume 10, 2021 - Issue 1
Original Research
Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma
, 
, , , , , , , , , , , , & show all
Elisabeth Lantéria Laboratory of Clinical and Experimental Pathology, Université Côte d’Azur, University Hospital Federation OncoAge, Pasteur Hospital, Nice, Francehttps://orcid.org/0000-0002-6664-6379View further author information
https://orcid.org/0000-0002-6664-6379View further author information, Emmanuel Chamoreyd Biostatistics Unit, Antoine Lacassagne Comprehensive Cancer Center, Nice, Francehttps://orcid.org/0000-0002-6841-4571View further author information
https://orcid.org/0000-0002-6841-4571View further author information, , , Henri Montaudiée Department of Dermatology, Université Côte d’Azur, Archet Hospital, Nice, Francehttps://orcid.org/0000-0002-0528-4829View further author information
https://orcid.org/0000-0002-0528-4829View further author information, , , Thierry Passerone Department of Dermatology, Université Côte d’Azur, Archet Hospital, Nice, Francehttps://orcid.org/0000-0002-0797-6570View further author information
https://orcid.org/0000-0002-0797-6570View further author information, Sandra Lassallea Laboratory of Clinical and Experimental Pathology, Université Côte d’Azur, University Hospital Federation OncoAge, Pasteur Hospital, Nice, France;b CNRS, INSERM, Institute of Research on Cancer and Ageing of Nice (IRCAN), Université Côte d’Azur, University Hospital Federation OncoAge, Nice, France;c The Department is the Biobank, Université Côte d’Azur, University Hospital Federation OncoAge, Hospital-Related Biobank (BB-0033-00025), Pasteur Hospital, Nice, Francehttps://orcid.org/0000-0003-1692-2440View further author information
https://orcid.org/0000-0003-1692-2440View further author information, Elodie Long-Miraa Laboratory of Clinical and Experimental Pathology, Université Côte d’Azur, University Hospital Federation OncoAge, Pasteur Hospital, Nice, France;b CNRS, INSERM, Institute of Research on Cancer and Ageing of Nice (IRCAN), Université Côte d’Azur, University Hospital Federation OncoAge, Nice, France;c The Department is the Biobank, Université Côte d’Azur, University Hospital Federation OncoAge, Hospital-Related Biobank (BB-0033-00025), Pasteur Hospital, Nice, Francehttps://orcid.org/0000-0002-1923-6713View further author information
https://orcid.org/0000-0002-1923-6713View further author information, Julien Cherfils-Vicinib CNRS, INSERM, Institute of Research on Cancer and Ageing of Nice (IRCAN), Université Côte d’Azur, University Hospital Federation OncoAge, Nice, Francehttps://orcid.org/0000-0001-7813-1527View further author information
https://orcid.org/0000-0001-7813-1527View further author information, Eric Gilsonb CNRS, INSERM, Institute of Research on Cancer and Ageing of Nice (IRCAN), Université Côte d’Azur, University Hospital Federation OncoAge, Nice, France;g Department of Medical Genetics, CHU Nice, Nice, Francehttps://orcid.org/0000-0001-5738-6723View further author information
https://orcid.org/0000-0001-5738-6723View further author information, & Paul Hofmana Laboratory of Clinical and Experimental Pathology, Université Côte d’Azur, University Hospital Federation OncoAge, Pasteur Hospital, Nice, France;b CNRS, INSERM, Institute of Research on Cancer and Ageing of Nice (IRCAN), Université Côte d’Azur, University Hospital Federation OncoAge, Nice, France;c The Department is the Biobank, Université Côte d’Azur, University Hospital Federation OncoAge, Hospital-Related Biobank (BB-0033-00025), Pasteur Hospital, Nice, FranceCorrespondence[email protected]
https://orcid.org/0000-0003-0431-9353View further author information
https://orcid.org/0000-0003-0431-9353View further author information show all